Shows
NGBiLabProteinQureMay 16th 2024 – This week we welcome Lucas Siow of ProteinQure based out of Toronto, Ontario to the show. Lucas and his team are pioneering novel peptide therapies with the help of quantum computing and have recently made a breakthrough in the realm of triple-negative breast cancer.ProteinQure: proteinqure.comGet Your Tickets to The NGBI Summit: nextgreatbigideas.comLab Occupier: laboccupier.com2024-05-1623 min
First In Human By VialEpisode 39: Lucas Siow - CEO & Co-Founder at ProteinQureEmbark on a journey into the forefront of biotech with Lucas Siow, the visionary behind ProteinQure, as he unveils the impact of his computational platform on peptide therapeutics and delves into the art of team building. Explore the fusion of medicinal chemistry and high throughput screens, discover the essence of benchmarking in drug discovery, and gain insights into creating a versatile, learning-focused team in the biotech landscape from their Toronto base.First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a...2023-09-0515 min
Artificial Intelligence in Drug DiscoveryLucas Siow of ProteinQure on AI for Protein-Based DrugsOn this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based drugs such as antibodies and peptides. On this episode, you'll learn the benefits of protein-based drugs, challenges with discovering them, and how ProteinQure has combined emerging technologies in what may be the most science fiction-sounding drug discovery startup I've seen yet.
This episode is brought to you by BenchSci ( www.benchsci.com ). BenchSci uses artificial intelligence to reduce the time, uncertainty, and cost of scientific experiments. Use it to find research antibodies up...2018-08-0733 min